- PR Newswire•last monthResearch Reports Coverage on Biotech Stocks -- OncoGenex Pharma, INSYS Therapeutics, Threshold Pharma, and AmpliPhi Biosciences
Under evaluation today are: OncoGenex Pharmaceuticals Inc. (OGXI), INSYS Therapeutics Inc. (INSY), Threshold Pharmaceuticals Inc. (THLD), and AmpliPhi Biosciences Corp. (NYSE MKT: APHB). On Wednesday, Washington headquartered OncoGenex Pharmaceuticals Inc.'s stock recorded a trading volume of 76,557 shares, and ended the session 1.14% higher at $0.56. The Company's shares have gained 11.13% in the last one month, 50.58% in the previous three months, and 11.48% on an YTD basis.
- Marketwired•2 months ago
Now in its fifth year, the 2017 Life Sciences Report Biotech Watchlist includes nineteen small-cap biotech companies selected by top analysts in the field, and will be presented at the Biotech Showcase ...
THLD : Summary for Threshold Pharmaceuticals, Inc. - Yahoo Finance
Threshold Pharmaceuticals, Inc. (THLD)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Bid||0.53 x 400|
|Ask||0.80 x 70000|
|Day's Range||0.55 - 0.62|
|52 Week Range||0.22 - 1.48|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||1.01|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|